Misoprostol and Mifepristone Are Now Classified as Controlled Substances in Louisiana
Beginning October 1, 2024, Louisiana’s Act 246 will take effect. This legislation adds mifepristone and misoprostol to the Schedule IV list of controlled dangerous substances
Supreme Court Punts in Moyle v. United States: A Setback for Reproductive Rights
The U.S. Supreme Court released an order in Idaho v. United States and Moyle v. United States declining to issue an opinion on the central issue these cases raised, which will determine whether Idaho’s restrictive abortion ban can be enforced against people who are in serious medical crisis and need an abortion to stabilize their condition and preserve their health.
Supreme Court Dismisses Baseless Mifepristone Case and Protects Abortion Medication
The Supreme Court of the United States delivered an opinion in FDA v. Alliance for Hippocratic Medicine preserving access to mifepristone, one of the two essential medications used in the abortion pill regimen.
Fifth Circuit Court of Appeals ruling limits the window for abortion seekers to take the drug
Last week, the Fifth Circuit Court of Appeals released an opinion that, if allowed to go into effect, would make it much more difficult to legally obtain and use Mifepristone to end a pregnancy.
Poll Reveals Majority of LA Voters Support Constitutional Right to Abortion
More voters consider themselves “pro-choice” than “pro-life”
Louisiana Coalition Responds To Abortion Win At Supreme Court
Louisiana Coalition For Reproductive Freedom celebrates Supreme Court win
Reproductive Freedom Coalition Responds to AG Landry’s COVID-19 Task Force
The coalition wants to ensure that patients can continue to access essential, time-sensitive abortion services during the COVID-19 pandemic.
What Happened Wednesday, and What's Next
Thousands of advocates, activists and allies rally outside the U.S. Supreme Court as the Center for Reproductive Rights argues a major abortion rights case just inside (June Medical Services v. Russo).